Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

DnaJC7 involvement in tau aggregation: Implicates for amyotrophic lateral sclerosis

EF 2024-25

Résumé
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron dysfunction. Pathological tau phosphorylation is a hallmark of ALS associated with chronic traumatic encephalopathy (ALS-CTE). Tau phosphorylation at threonine 175 (Thr175) induces the phosphorylation of Thr231 and promotes tau aggregation, contributing to disease progression. DNAJC7 is a novel gene with mutations implicated in the pathogenesis of ALS. The protein DnaJC7, encoded by the gene DNAJC7, has been shown to interact with tau and can reduce the presence of tau aggregates. However, 99% of mutations in DNAJC7 result in loss-of-function of DnaJC7, disrupting its protective role and increasing the presence of tau aggregates. Upon phosphorylation of Thr175 tau, DnaJC7 dissociates from tau, although the exact time and cause of this dissociation is unknown. This study aims to examine the mechanisms behind the dissociation of DnaJC7 from tau in a model of ALS-CTE. Using an in vitro HEK293T cell model, we will: (1) Investigate the effects of Thr175 tau phosphorylation on PAD exposure, Thr231 tau phosphorylation, and DnaJC7 expression, (2) Determine the timing and causation of DnaJC7 dissociation from tau following Thr175 tau phosphorylation. Western blot and immunoprecipitation assays will assess protein interactions and identify the critical window during which DnaJC7 dissociates, allowing tau aggregation to proceed. By uncovering how the dissociation of DnaJC7 contributes to tau aggregation, this research will provide insight into tauopathies, including ALS-CTE and Alzheimer's disease. Ultimately, this research will advance our understanding of the molecular pathways involved in tau aggregation and its role in the progression of ALS-CTE and related tauopathies.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530262
Name
Palik Jacqueline
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
DnaJC7 involvement in tau aggregation: Implicates for amyotrophic lateral sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Als (Amyotrophic Lateral Sclerosis); Chaperone-Mediated Pathways; Dnajc7; Genetic Risk Factors; In Vitro Cell Culture; Neurodegenerative Disease; Protein Aggregation; Tau Protein; Translational Neuroscience; Western Blot
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron dysfunction. Pathological tau phosphorylation is a hallmark of ALS associated with chronic traumatic encephalopathy (ALS-CTE). Tau phosphorylation at threonine 175 (Thr175) induces the phosphorylation of Thr231 and promotes tau aggregation, contributing to disease progression. DNAJC7 is a novel gene with mutations implicated in the pathogenesis of ALS. The protein DnaJC7, encoded by the gene DNAJC7, has been shown to interact with tau and can reduce the presence of tau aggregates. However, 99% of mutations in DNAJC7 result in loss-of-function of DnaJC7, disrupting its protective role and increasing the presence of tau aggregates. Upon phosphorylation of Thr175 tau, DnaJC7 dissociates from tau, although the exact time and cause of this dissociation is unknown. This study aims to examine the mechanisms behind the dissociation of DnaJC7 from tau in a model of ALS-CTE. Using an in vitro HEK293T cell model, we will: (1) Investigate the effects of Thr175 tau phosphorylation on PAD exposure, Thr231 tau phosphorylation, and DnaJC7 expression, (2) Determine the timing and causation of DnaJC7 dissociation from tau following Thr175 tau phosphorylation. Western blot and immunoprecipitation assays will assess protein interactions and identify the critical window during which DnaJC7 dissociates, allowing tau aggregation to proceed. By uncovering how the dissociation of DnaJC7 contributes to tau aggregation, this research will provide insight into tauopathies, including ALS-CTE and Alzheimer's disease. Ultimately, this research will advance our understanding of the molecular pathways involved in tau aggregation and its role in the progression of ALS-CTE and related tauopathies.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Palik, Jacqueline
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~